Predator CEO Paul Griffiths looks to do a CO2 sequestration deal with Bahamas Petroleum Watch Now

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.70
Bid: 7.60
Ask: 7.80
Change: 0.00 (0.00%)
Spread: 0.20 (2.63%)
Open: 7.70
High: 7.70
Low: 7.70
Yest. Close: 7.70
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

13 Jul 20 18:25

UK DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Chair Pays GBP860,000

UK DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Chair Pays GBP860,000

30 Jun 20 17:07

IN BRIEF: Hemogenyx Inks Investigation And Material Supply Deal

IN BRIEF: Hemogenyx Inks Investigation And Material Supply Deal

26 Jun 20 14:50

IN BRIEF: Hemogenyx To Take Next Steps In Developing Virus Treatment

IN BRIEF: Hemogenyx To Take Next Steps In Developing Virus Treatment

15 Jun 20 17:54

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

2 Jun 20 12:57

Hemogenyx Pharma Placing Raises GBP2.5 Million To Fund Studies

Hemogenyx Pharma Placing Raises GBP2.5 Million To Fund Studies

12 May 20 18:09

UK EARNINGS SUMMARY: InfraStrata Targets Breakeven At Titanic Shipyard

UK EARNINGS SUMMARY: InfraStrata Targets Breakeven At Titanic Shipyard

1 May 20 11:18

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

22 Apr 20 15:40

Hemogenyx Approved For And Issued Hu-PHEC Patent In Europe

Hemogenyx Approved For And Issued Hu-PHEC Patent In Europe

22 Apr 20 06:55

Hemogenyx Reports Positive Test Results From Cancer Therapy Treatment

Hemogenyx Reports Positive Test Results From Cancer Therapy Treatment

20 Feb 20 15:15

Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells

Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells

11 Feb 20 12:00

Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development

Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development

30 Jan 20 15:47

Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy

Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy

15 Jan 20 13:23

Hemogenyx CDX Antibody Treatment Potentially "Life-Saving"

Hemogenyx CDX Antibody Treatment Potentially "Life-Saving"

18 Nov 19 11:51

Hemogenyx signs another deal with unnamed global pharma company

(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.

23 Oct 19 10:43
12

Login to your account

Don't have an account? Click here to register.